The Algorithmic Toll Booth: How Medicare's GLP-1 Cap Restructures Pharmaceutical Access
CMS has capped GLP-1 out-of-pocket costs in Medicare while mandating algorithmic prior authorization. This analysis diss...
Read More →Government policies, insurance, and healthcare systems.
CMS has capped GLP-1 out-of-pocket costs in Medicare while mandating algorithmic prior authorization. This analysis diss...
Read More →The simultaneous mandate of AI-driven prior authorization and episode-based value reimbursement by CMS and major commerc...
Read More →A landmark 2026 Boston University study reveals that the NFL Concussion Settlement's standardized testing systematically...
Read More →[The convergence of the CMS 2027 Physician Fee Schedule, state PBM transparency laws, FDA OTC CGM clearances, NIH AI-tri...
Read More →September 2026 has unleashed five transformative healthcare policy shifts: hospital price transparency enforcement revea...
Read More →The American healthcare system is undergoing a violent structural recalibration, driven by Medicaid unwinding, PBM antit...
Read More →The 2026 healthcare policy landscape is defined by the removal of 760,000 ACA enrollees and landmark PBM reforms, yet th...
Read More →[The convergence of the 2026 Medicare Drug Price Negotiation, landmark PBM reform, and Medicaid unwinding has triggered ...
Read More →September 2026 exposed the structural fragility of the U.S. healthcare system, highlighted by aggressive FTC antitrust e...
Read More →The 2026 healthcare policy landscape is defined by Medicare drug price negotiation expansion and severe state-level frag...
Read More →